These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 24002698)

  • 21. [Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].
    Sun MH; Yang F; Shen L; Zhang L; Chen Y; Cai X; Zhu XL; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):655-9. PubMed ID: 22321541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
    Chou TY; Chiu CH; Li LH; Hsiao CY; Tzen CY; Chang KT; Chen YM; Perng RP; Tsai SF; Tsai CM
    Clin Cancer Res; 2005 May; 11(10):3750-7. PubMed ID: 15897572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.
    Kimura H; Kasahara K; Kawaishi M; Kunitoh H; Tamura T; Holloway B; Nishio K
    Clin Cancer Res; 2006 Jul; 12(13):3915-21. PubMed ID: 16818687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of acquired resistance-related molecules in Japanese patients with NSCLC treated with an EGFR-TKI.
    Uramoto H; Yamada T; Yano S; Kondo N; Hasegawa S; Tanaka F
    Anticancer Res; 2012 Sep; 32(9):3785-90. PubMed ID: 22993320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity.
    Han HS; Lim SN; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Son SM; Choi SY; Lee HC; Lee OJ
    J Thorac Oncol; 2012 Feb; 7(2):355-64. PubMed ID: 22157369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer.
    Zhang X; Zhao Y; Wang M; Yap WS; Chang AY
    Lung Cancer; 2008 May; 60(2):175-82. PubMed ID: 18061305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification Process.
    Hoshi K; Takakura H; Mitani Y; Tatsumi K; Momiyama N; Ichikawa Y; Togo S; Miyagi T; Kawai Y; Kogo Y; Kikuchi T; Kato C; Arakawa T; Uno S; Cizdziel PE; Lezhava A; Ogawa N; Hayashizaki Y; Shimada H
    Clin Cancer Res; 2007 Sep; 13(17):4974-83. PubMed ID: 17785547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells.
    Molina-Vila MA; Bertran-Alamillo J; Reguart N; Taron M; Castellà E; Llatjós M; Costa C; Mayo C; Pradas A; Queralt C; Botia M; Pérez-Cano M; Carrasco E; Tomàs M; Mate JL; Moran T; Rosell R
    J Thorac Oncol; 2008 Nov; 3(11):1224-35. PubMed ID: 18978556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients.
    Cho MC; Choi CM; Kim S; Jang S; Jang S; Park CJ; Chi HS; Peyton MJ; Lee W; Chun S; Kim SW; Min WK
    Clin Chem Lab Med; 2011 Sep; 50(3):565-72. PubMed ID: 21899495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of epidermal growth factor receptor gene mutations in advanced non-small cell lung cancer].
    Wang S; Han XH; Li JL; Hu XS; Wang XY; Gui L; Zhao LD; Sun Y; Shi YK
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):530-3. PubMed ID: 23157744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer.
    Tokumo M; Toyooka S; Ichihara S; Ohashi K; Tsukuda K; Ichimura K; Tabata M; Kiura K; Aoe M; Sano Y; Date H; Shimizu N
    Lung Cancer; 2006 Jul; 53(1):117-21. PubMed ID: 16730855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy.
    Sunaga N; Tomizawa Y; Yanagitani N; Iijima H; Kaira K; Shimizu K; Tanaka S; Suga T; Hisada T; Ishizuka T; Saito R; Dobashi K; Mori M
    Lung Cancer; 2007 Jun; 56(3):383-9. PubMed ID: 17368623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patients.
    Chang JW; Liu HP; Hsieh MH; Fang YF; Hsieh MS; Hsieh JJ; Chiu YT; Tsai HY; Chen YH; Chen YT; Hsu HY; Chen YT; Tsai SF; Chen YR; Hsi BL; Huang SF
    Lung Cancer; 2008 Sep; 61(3):328-39. PubMed ID: 18304690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct serum and tissue assay for EGFR mutation in non-small cell lung cancer by high-resolution melting analysis.
    Hu C; Liu X; Chen Y; Sun X; Gong Y; Geng M; Bi L
    Oncol Rep; 2012 Nov; 28(5):1815-21. PubMed ID: 22923193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of ARMS and direct sequencing for detection of EGFR mutation and prediction of EGFR-TKI efficacy between surgery and biopsy tumor tissues in NSCLC patients.
    Shaozhang Z; Ming Z; Haiyan P; Aiping Z; Qitao Y; Xiangqun S
    Med Oncol; 2014 May; 31(5):926. PubMed ID: 24748405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay.
    Endo K; Konishi A; Sasaki H; Takada M; Tanaka H; Okumura M; Kawahara M; Sugiura H; Kuwabara Y; Fukai I; Matsumura A; Yano M; Kobayashi Y; Mizuno K; Haneda H; Suzuki E; Iuchi K; Fujii Y
    Lung Cancer; 2005 Dec; 50(3):375-84. PubMed ID: 16199108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of epidermal growth factor receptor gene mutations in non-small cell lung cancers by real-time polymerase chain reaction using scorpion amplification refractory mutation system].
    Zhang J; Liang ZY; Zeng X; Wu SF; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):294-9. PubMed ID: 18956645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors.
    Cohen V; Agulnik JS; Ang C; Kasymjanova G; Batist G; Small D; Brandao G; Chong G; Miller WH
    Cancer; 2010 Sep; 116(18):4309-17. PubMed ID: 20549828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantum dots immunofluorescence histochemical detection of EGFR gene mutations in the non-small cell lung cancers using mutation-specific antibodies.
    Qu YG; Zhang Q; Pan Q; Zhao XD; Huang YH; Chen FC; Chen HL
    Int J Nanomedicine; 2014; 9():5771-8. PubMed ID: 25525358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer.
    Yi S; Zhuang Y; Zhou J; Ma H; Huang J; Wang L; Zhu W; Kang S; Guo L; Guo F
    Int J Mol Med; 2014 Aug; 34(2):464-74. PubMed ID: 24891042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.